Celldex Therapeutics reported $-67.04M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AbbVie USD 186M 752M Sep/2025
Amgen USD 1.33B 1.88B Dec/2025
Bristol-Myers Squibb USD 2.2B 891M Sep/2025
Celldex Therapeutics USD -67.04M 10.44M Sep/2025
Glaxosmithkline GBP 2.71B 1.27B Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025